Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome-Reference-Cited by-同舟云学术

Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome

Published:2023-08-03 Issue:8 Volume:32 Page:693-704
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Kuhn Katrina¹,Lederman Howard M.²,McGrath-Morrow Sharon A.³

Affiliation:

1. Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2. Eudowood Division of Pediatric, Allergy and Immunology, Johns Hopkins School of Medicine, Baltimore, MD, USA

3. Children’s Hospital of Philadelphia Division of Pulmonary Medicine and Sleep and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2249399

Reference121 articles.

1. Ataxia telangiectasia: a review

2. Survival probability in ataxia telangiectasia

3. Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis

4. Assessing cardiovascular risk in ATM heterozygotes

5. Mild Neurological Phenotype Associated with Hypomorphic Variants in the Ataxia‐Telangiectasia Mutated Gene

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial;The Lancet Neurology;2024-09

2. Genetic insights into the complexity of premature ovarian insufficiency;Reproductive Biology and Endocrinology;2024-08-02

3. The importance of synthetic pharmacotherapy for recessive cerebellar ataxias;Expert Review of Neurotherapeutics;2024-07-09

4. Microglial inflammation in genome instability: A neurodegenerative perspective;DNA Repair;2024-03